163 related articles for article (PubMed ID: 32979556)
21. A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes.
Binkley E; Triozzi PL; Rybicki L; Achberger S; Aldrich W; Singh A
Br J Ophthalmol; 2020 Apr; 104(4):524-528. PubMed ID: 31371315
[TBL] [Abstract][Full Text] [Related]
22. Survival from uveal melanoma in Western Australia 1981-2005.
Chew AL; Spilsbury K; Isaacs TW
Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
[TBL] [Abstract][Full Text] [Related]
23. Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013).
Aronow ME; Topham AK; Singh AD
Ocul Oncol Pathol; 2018 Apr; 4(3):145-151. PubMed ID: 29765944
[TBL] [Abstract][Full Text] [Related]
24. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma.
Kroll S; Char DH; Quivey J; Castro J
Ophthalmology; 1998 Nov; 105(11):2035-45. PubMed ID: 9818602
[TBL] [Abstract][Full Text] [Related]
25. Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients.
Bol KF; Mensink HW; Aarntzen EH; Schreibelt G; Keunen JE; Coulie PG; de Klein A; Punt CJ; Paridaens D; Figdor CG; de Vries IJ
Am J Ophthalmol; 2014 Nov; 158(5):939-47. PubMed ID: 25038326
[TBL] [Abstract][Full Text] [Related]
26. Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin.
Shields CL; Welch RJ; Malik K; Acaba-Berrocal LA; Selzer EB; Newman JH; Mayro EL; Constantinescu AB; Spencer MA; McGarrey MP; Knapp AN; Graf AE; Altman AJ; Considine SP; Shields JA
Middle East Afr J Ophthalmol; 2018; 25(2):81-90. PubMed ID: 30122853
[TBL] [Abstract][Full Text] [Related]
27. Conditional Metastasis of Uveal Melanoma in 8091 Patients over Half-Century (51 Years) by Age Group: Assessing the Entire Population and the Extremes of Age.
Shields CL; Samuelson AG; Oh GJ; DeSimone JD; Sajjadi ZL; Bas Z; Kalafatis NE; Lally SE; Shields JA; Dockery PW
Invest Ophthalmol Vis Sci; 2023 Jul; 64(10):7. PubMed ID: 37418273
[TBL] [Abstract][Full Text] [Related]
28. Variates of survival in metastatic uveal melanoma.
Rietschel P; Panageas KS; Hanlon C; Patel A; Abramson DH; Chapman PB
J Clin Oncol; 2005 Nov; 23(31):8076-80. PubMed ID: 16258106
[TBL] [Abstract][Full Text] [Related]
29. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe.
Mallone S; De Vries E; Guzzo M; Midena E; Verne J; Coebergh JW; Marcos-Gragera R; Ardanaz E; Martinez R; Chirlaque MD; Navarro C; Virgili G;
Eur J Cancer; 2012 May; 48(8):1167-75. PubMed ID: 22119735
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma.
Walter SD; Chao DL; Feuer W; Schiffman J; Char DH; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):734-40. PubMed ID: 27123792
[TBL] [Abstract][Full Text] [Related]
31. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
[TBL] [Abstract][Full Text] [Related]
32. Salvage proton beam therapy in local recurrent uveal melanoma.
Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
[TBL] [Abstract][Full Text] [Related]
33. Posterior uveal melanoma incidence and survival by AJCC tumour size in a 70-year nationwide cohort.
Smidt-Nielsen I; Bagger M; Heegaard S; Andersen KK; Kiilgaard JF
Acta Ophthalmol; 2021 Dec; 99(8):e1474-e1482. PubMed ID: 33738986
[TBL] [Abstract][Full Text] [Related]
34. Variability of Bad Prognosis in Uveal Melanoma.
Shao YF; Echegaray JJ; Singh N; Singh AD
Ophthalmol Retina; 2019 Feb; 3(2):186-193. PubMed ID: 31014770
[TBL] [Abstract][Full Text] [Related]
35. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
[TBL] [Abstract][Full Text] [Related]
36. Conditional survival of uveal melanoma using The Cancer Genome Atlas (TCGA) classification (Simplified Version) in 1001 cases.
Shields CL; Dockery PW; Mayro EL; Bas Z; Yaghy A; Lally SE; Orloff M; Sato T; Shields JA
Saudi J Ophthalmol; 2022; 36(3):308-314. PubMed ID: 36276251
[TBL] [Abstract][Full Text] [Related]
37. Uveal melanoma survival in Sweden from 1960 to 1998.
Bergman L; Seregard S; Nilsson B; Lundell G; Ringborg U; Ragnarsson-Olding B
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3282-7. PubMed ID: 12882771
[TBL] [Abstract][Full Text] [Related]
38. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
Kim IK; Lane AM; Gragoudas ES
Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
40. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW
Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
